S

Sionna Therapeutics

29 employees

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
drug development
clinical development
lung
clinical study
research
biotechnology
chemistry
genetic mutation
life sciences
genetics
small molecule
Genetics
protein function
patient advocacy
pharmaceuticals
orphan disease
clinical research
Health Care
genetic disease
Therapeutics
cystic fibrosis
Medical
rare disease
molecular engineering

Date founded

2019

Funding rounds raised

Total raised

$110M

from 4 investors over 4 rounds

S

Sionna Therapeutics raised $110M on April 19, 2022

Investors: OrbiMed Advisors, RA Capital Management, L.P., Atlas Venture and T. Rowe Price

FAQ